NCT00589706 · Interventional trial
A Phase II Study of Adjuvant Use of Anti-Epidermal Growth Factor Receptor EGFR-425 in High Grade Gliomas
Overall registry status Completed
Phase 2
Conditions Gliomas
Delaware Valley sites
- Hahneman Hospital · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory